Barriers Hinder PrEP Uptake Among Cisgender Black Women, Experts Say

Kaiser Health News (10/12, Whitehead) reports that “more than a decade after the first PrEP drug was approved for the U.S. market, one of the groups that would benefit most from the medications isn’t taking them: Black women...whose gender identity align...